Chester County News and Community Website
WASHINGTON, D.C. — The U.S. Food and Drug Administration on Friday placed Sarepta Therapeutics’ gene therapy trials for limb girdle muscular dystrophy on clinical hold following the deaths of three patients …
FDA Shuts Down Sarepta Gene Therapy Trials After Three Deaths Linked to Liver Failure Read More
HARRISBURG, PA — A federal bankruptcy court has approved the sale of genetic testing company 23andMe to the newly formed TTAM Research Institute, a non-profit medical research organization created by 23andMe …
Bankruptcy Court Approves 23andMe Sale to Non-Profit Focused on Privacy and Research Read More
HARRISBURG, PA — A coalition of 28 Attorneys General, led by Pennsylvania Attorney General Dave Sunday, has filed a lawsuit to prevent the sale of sensitive consumer genetic data by 23andMe …
Outrage Erupts Over 23andMe’s Plan to Auction Your Genetic Data Read More
WASHINGTON, D.C. — Federal Trade Commission Chairman Andrew N Ferguson issued a letter on March 31 addressing the U.S. Trustee overseeing 23andMe’s Chapter 11 bankruptcy, highlighting concerns about the potential …
FTC Sounds Alarm on 23andMe Bankruptcy: Privacy Fears Loom Over Genetic Data Sale Read More
WEST CHESTER, PA — Pathways Neuro Pharma, Inc. has announced a strategic partnership with Dragonfly 44 Capital, a move set to bolster the company’s financial and strategic capabilities. The agreement, …
Pathways Neuro Pharma Engages Dragonfly 44 Capital as Strategic Advisor Read More
MALVERN, PA — In a promising development for the treatment of Stargardt disease, Ocugen, Inc. (NASDAQ: OCGN), a biotechnology company based in Chester County, Pennsylvania, has announced the completion of …
Ocugen Achieves Clinical Milestone in Stargardt Disease Treatment Read More